Network Packaging Partners

mobile trigger

Impacts to Pharma on Falsified Medicines Directive Compliance

Supply Chain Security Partners’┬áManaging Director on the pharmaceutical supply chain, evolving traceability regulations and impacts to manufacturers, “Big pharma will be spending hundreds of millions of dollars to be compliant with the Falsified Medicines Directive and new regulatory regimes in countries like the US and China. They would not invest that amount of money without a return of value to the business, except this is about regulatory compliance.”

Read the Full Article at European Packaging Magazine.